Related Experiment Videos
Hand-assisted laparoscopic radical nephrectomy: comparison with transabdominal radical nephrectomy
Gregory J Mancini1, Leslie A McQuay, Frederick A Klein
1Graduate School of Medicine, University of Tennessee, Knoxville, USA.
The American Surgeon
|February 15, 2002
Summary
Hand-assisted laparoscopic radical nephrectomy (HALN) is an effective alternative for renal tumors, showing reduced blood loss and pain medication use compared to open surgery. Further research may reveal its superiority.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Renal cancer treatment often involves radical nephrectomy.
- Minimally invasive techniques aim to improve patient outcomes.
- Hand-assisted laparoscopy offers a hybrid approach to complex surgeries.
Purpose of the Study:
- To compare the efficacy and outcomes of hand-assisted laparoscopic radical nephrectomy (HALN) versus traditional transabdominal radical nephrectomy.
- To evaluate HALN as a definitive oncologic procedure for renal cancers.
Main Methods:
- Retrospective, nonrandomized study comparing 12 HALN cases with 12 transabdominal radical nephrectomies.
- Patients preoperatively diagnosed with renal mass were included.
- Data collected included comorbidities, operative time, blood loss, length of stay, and postoperative complications.
Main Results:
- HALN patients had more comorbidities (P=0.032) but significantly less estimated blood loss (83 vs 318 cm³, P=0.001) and shorter need for pain medication (P=0.016).
- Operative time was longer for HALN (103 vs 57 min, P=0.001), but complication rates were similar.
- HALN was associated with larger tumor sizes (6.8 vs 4.2 cm, P=0.012) and achieved negative margins in all cases.
Conclusions:
- Hand-assisted laparoscopic radical nephrectomy is an effective alternative to open surgery for renal tumors, demonstrating advantages in blood loss and pain management.
- Despite selection bias towards sicker patients in the HALN group, outcomes suggest potential benefits.
- Larger, prospective randomized trials are warranted to definitively establish the superiority of HALN.